Skip to content Skip to sidebar Skip to footer

Newsletter

Technology

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

There are hard questions investors need to ask about their portfolio every now and again, because anyone telling you there's such a thing as a 'set and forget' investment is wrong. Markets evolve, company fundamentals shift, and macro conditions change, yet many portfolios are left largely unchecked. The most rational approach is to periodically interrogate…

ByNick SundichMarch 31, 2026

Botanix (ASX: BOT) The Bleeding Has Stopped, Now Comes the Hard Part

Cash Burn Slowing, Execution Risk Rising Botanix announced an important update on its supplier payment terms, which gives investors much better visibility around the company’s cash runway. For many investors following the stock, cash burn has been one of the biggest concerns. That is why the recent placement at 6 cents per share came as such…

ByCharlie YouldenMarch 30, 2026

Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside

Atomo Diagnostics A$4m Raise Funds Scale-Up as FebriDx US Rollout Accelerates Atomo Diagnostics has just completed a fresh capital raise to fund growth. The company raised A$4M through a A$3M placement and a A$1M share purchase plan. The new shares were issued at 3.3 cents each, which represented a 10% discount to the company’s 15-day moving…

ByCharlie YouldenMarch 30, 2026

The ASX’s Good Fame and Character Test: The Potential Listing of Oliver Curtis’ $6bn AI Company Firmus Meant A Clarification Was Needed

The ASX's Good Fame and Character Test is not new. But the possible listing of Oliver Curtis' Firmus meant investors are paying more attention than they otherwise would. You see, the Australian Securities Exchange does not let just anyone run a listed company. Before an entity joins its official list, the ASX requires that every director,…

ByNick SundichMarch 30, 2026

4DMedical (ASX:4DX) Just Hit A$3.6B, CE Mark Approved, Now the Hard Part Starts

Two Bull Catalysts, One Huge Valuation Question 4DMedical has had two bullish catalysts help push the company to a A$3.6B valuation. We started covering 4DMedical at 25 cents and have now seen it grow from a micro-cap into one of the top ASX performers, with a lot of future expectations now built into the share…

ByCharlie YouldenMarch 27, 2026

Weebit Nano (ASX:WBT) Accelerates AI Memory With A$150m Cash

Down After the Raise, But Onsemi & Texas Instruments Are the Real Catalyst Weebit Nano opened below the placement price today, which means the institutions that participated are already sitting in the red. Even so, the company successfully completed a fully underwritten A$80M placement, plus a A$7M Israeli placement, taking total proceeds to A$87M. The company…

ByCharlie YouldenMarch 27, 2026

How Google’s “turboquant” caused a mass sell-off in the semiconductor space

The mass sell-off in the semiconductor space The semiconductor sector came under pressure, with Nvidia down 2.4%, AMD falling 5.5%, TSMC down 4.5%, and Micron dropping 4.6%, leaving it down 14% over the past five trading days. Western Digital fell 4.7%, and Sandisk dropped 8%. The selloff was driven by Google’s recent TurboQuant announcement, which uses…

ByCharlie YouldenMarch 27, 2026

Xero and Anthropic announce a partnership! It looks like a win-win, but does it reek of desperation amidst investor panic over AI?

Xero and Anthropic have just unveiled a strategic partnership. The press release this morning did what all press releases of this kind would do: frame it as a win win for both sides...but of course few deals truly turn out like that. In the short-term, Xero will be the winner because investors worried it'll go…

ByNick SundichMarch 27, 2026

The Data Centre Backlash Is Legitimate, Will It Threaten Companies like NextDC?

The global boom in artificial intelligence and cloud computing has turbocharged demand for data centres, but also turbocharged a data centre backlash. In Australia (and elsewhere), demand for data centres is colliding hard with electricity and water (two of the most important but finite resources on the planet) and the friction is producing a backlash.…

ByNick SundichMarch 27, 2026

A SpaceX IPO could be the biggest IPO ever! Will this endeavour of Elon Musk’s be successful?

A SpaceX IPO looks like it is on. It is not the first venture of Elon Musk's to list, but this one could be the largest ever IPO in terms of capital raised and the value of the company, it would be over US$1tn barring a highly unlikely cut in the most recent private valuation!…

ByNick SundichMarch 27, 2026

the Kick-ass Multipurpose WordPress Theme

Technology

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

Botanix (ASX: BOT) The Bleeding Has Stopped, Now Comes the Hard Part

Atomo Diagnostics (ASX:AT1) Raises A$4m as FebriDx CLIA Waiver Unlocks Pascal Volume Upside

The ASX’s Good Fame and Character Test: The Potential Listing of Oliver Curtis’ $6bn AI Company Firmus Meant A Clarification Was Needed

4DMedical (ASX:4DX) Just Hit A$3.6B, CE Mark Approved, Now the Hard Part Starts

Weebit Nano (ASX:WBT) Accelerates AI Memory With A$150m Cash

How Google’s “turboquant” caused a mass sell-off in the semiconductor space

Xero and Anthropic announce a partnership! It looks like a win-win, but does it reek of desperation amidst investor panic over AI?

The Data Centre Backlash Is Legitimate, Will It Threaten Companies like NextDC?

A SpaceX IPO could be the biggest IPO ever! Will this endeavour of Elon Musk’s be successful?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Technology

Stocks in Spotlight

Add Your Heading Text Here